MENU
INTS
AS OF
Nov 13, 04:59 PM (EDT)
Price
$0.48
Change
-$0.03 (-5.88%)
Capitalization
30.61M
119 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
INTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Intensity Therapeutics (INTS) Earnings Date & Reports

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers... Show more

A.I. Advisor
published Earnings

INTS is expected to report earnings to -5 cents per share on March 12

Intensity Therapeutics INTS Stock Earnings Reports
Q4'25
Est.
$-0.06
Q3'25
Est.
$-0.06
Q2'25
Beat
by $0.03
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.95
The last earnings report on November 07 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 3.21M shares outstanding, the current market capitalization sits at 30.61M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
INTS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INTS showed earnings on November 07, 2025. You can read more about the earnings report here.
View AI-Driven Trading for INTS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
17
Web
https://www.intensitytherapeutics.com